Documenti full-text disponibili:
Abstract
Increasing evidence links the gut microbiome to the development and progression of colorectal cancer (CRC). However, most microbiome studies have focused primarily on taxonomic composition and functional profiling based on known metabolic pathways, while the role of microbial biosynthetic gene clusters (BGCs) and their encoded specialized metabolites remain largely unexplored. Despite the remarkable diversity of microbial BGCs, CRC-protective bioactive natural compounds directly linked to healthy gut microbiota BGCs have not yet been clearly identified. Here, we investigated BGCs within de novo gut metagenome-assembled genomes reconstructed from 559 individuals, including healthy controls, adenoma and CRC patients. High-quality metagenome-assembled genomes were screened for BGCs using genome mining tools such as AntiSMASH. Comparative analyses identified distinct BGC abundance distribution patterns across the three groups, with four BGCs significantly enriched in healthy individuals compared to adenoma and CRC patients. One of these BGCs was predicted to be involved in the biosynthesis of a metabolite closely related to curacin-A, an anticancer compound originally described in marine cyanobacteria (Lyngbya majuscula) and known for its antiproliferative activity. Structural domain analysis and homology-based predictions supported the presence of key enzymatic modules compatible with the synthesis of a curacin-like compound via a CurF-like enzymatic machinery. Notably, this BGC was also overrepresented in healthy centenarians, suggesting a potential role in maintaining long-term cancer-free health and microbiome-associated resilience during aging. Overall, our findings provide evidence that specific gut microbial BGCs are associated with CRC protection and may encode previously uncharacterized bioactive molecules. This study highlights the importance of exploring gut microbiota BGCs as a source of novel compounds for cancer prevention and treatment.
Abstract
Increasing evidence links the gut microbiome to the development and progression of colorectal cancer (CRC). However, most microbiome studies have focused primarily on taxonomic composition and functional profiling based on known metabolic pathways, while the role of microbial biosynthetic gene clusters (BGCs) and their encoded specialized metabolites remain largely unexplored. Despite the remarkable diversity of microbial BGCs, CRC-protective bioactive natural compounds directly linked to healthy gut microbiota BGCs have not yet been clearly identified. Here, we investigated BGCs within de novo gut metagenome-assembled genomes reconstructed from 559 individuals, including healthy controls, adenoma and CRC patients. High-quality metagenome-assembled genomes were screened for BGCs using genome mining tools such as AntiSMASH. Comparative analyses identified distinct BGC abundance distribution patterns across the three groups, with four BGCs significantly enriched in healthy individuals compared to adenoma and CRC patients. One of these BGCs was predicted to be involved in the biosynthesis of a metabolite closely related to curacin-A, an anticancer compound originally described in marine cyanobacteria (Lyngbya majuscula) and known for its antiproliferative activity. Structural domain analysis and homology-based predictions supported the presence of key enzymatic modules compatible with the synthesis of a curacin-like compound via a CurF-like enzymatic machinery. Notably, this BGC was also overrepresented in healthy centenarians, suggesting a potential role in maintaining long-term cancer-free health and microbiome-associated resilience during aging. Overall, our findings provide evidence that specific gut microbial BGCs are associated with CRC protection and may encode previously uncharacterized bioactive molecules. This study highlights the importance of exploring gut microbiota BGCs as a source of novel compounds for cancer prevention and treatment.
Tipologia del documento
Tesi di dottorato
Autore
Leuzzi, Daniela
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
38
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Gut microbiome - Biosynthetic gene clusters - Colorectal cancer - Curacin A - Secondary metabolites - Centenarian
Data di discussione
17 Luglio 2026
URI
Altri metadati
Tipologia del documento
Tesi di dottorato
Autore
Leuzzi, Daniela
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
38
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Gut microbiome - Biosynthetic gene clusters - Colorectal cancer - Curacin A - Secondary metabolites - Centenarian
Data di discussione
17 Luglio 2026
URI
Gestione del documento: